Mary Slatter Selected Research

Mary Slatter Research Topics

Disease

9	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2023 - 02/2014
9	Infections 02/2023 - 03/2011
8	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2022 - 03/2011
3	Bronchiolitis Obliterans Syndrome 12/2023 - 01/2019
3	Primary Immunodeficiency Diseases 12/2021 - 01/2018
2	COVID-19 02/2023 - 01/2021
2	Immune System Diseases (Immune Disorders) 01/2022 - 03/2009
2	Lymphopenia (Lymphocytopenia) 01/2021 - 01/2017
2	Cytopenia 01/2020 - 01/2018
2	Viremia 01/2018 - 01/2017
2	Virus Diseases (Viral Diseases) 01/2018 - 01/2017
2	Chronic Granulomatous Disease 01/2016 - 02/2014
2	Severe combined immunodeficiency due to adenosine deaminase deficiency 06/2014 - 10/2012
1	Poliomyelitis (Polio) 01/2023
1	Fever (Fevers) 01/2022
1	Activated PI3K-delta Syndrome 01/2022
1	Hemorrhage 12/2021
1	Leukocyte adhesion deficiency type 1 12/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Schimke immunoosseous dysplasia 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Thrombotic Microangiopathies 01/2020
1	Pathologic Complete Response 01/2020
1	Tetanus 01/2020
1	Liver Diseases (Liver Disease) 01/2018
1	Inflammation (Inflammations) 01/2018
1	Type 1 Hyper-IgM Immunodeficiency Syndrome 04/2017
1	Immune Reconstitution Inflammatory Syndrome 01/2017
1	Reticular dysgenesis 01/2017
1	Diarrhea 01/2017
1	Colic (Abdominal Cramps) 01/2017
1	Warts (Wart) 11/2016
1	Agammaglobulinemia (Hypogammaglobulinemia) 11/2016
1	Primary Myelofibrosis (Myelosclerosis) 11/2016
1	Hematologic Neoplasms (Hematological Malignancy) 01/2016
1	Lymphoma (Lymphomas) 01/2016
1	Leukemia 01/2016
1	X-Linked Syndrome Enteropathy Polyendocrinopathy Immune Dysregulation 01/2015
1	Hypothyroidism 08/2013
1	Graves Disease (Basedow Disease) 08/2013
1	Wiskott-Aldrich Syndrome 08/2011
1	Failure to Thrive 05/2011
1	Sepsis (Septicemia) 05/2011

Drug/Important Bio-Agent (IBA)

2	Alemtuzumab (Campath)FDA Link 12/2023 - 01/2020
2	VaccinesIBA 01/2023 - 01/2020
2	Adenosine DeaminaseIBA 01/2022 - 10/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 05/2011
2	SteroidsIBA 01/2020 - 01/2016
2	Sirolimus (Rapamycin)FDA Link 01/2020 - 01/2018
2	treosulfanIBA 01/2016 - 01/2016
1	LactamsIBA 01/2022
1	Immunoglobulin A (IgA)IBA 11/2021
1	blinatumomabIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018
1	Immunoglobulin M (IgM)IBA 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	STAT1 Transcription FactorIBA 01/2018
1	brincidofovirIBA 01/2017
1	Cidofovir (Vistide)FDA Link 01/2017
1	Busulfan (Busulfex)FDA Link 01/2016
1	Indicators and Reagents (Reagents)IBA 06/2014
1	Janus Kinase 3IBA 06/2014
1	Long-Acting Thyroid Stimulator (LATS)IBA 08/2013
1	Thyroid HormonesIBA 08/2013
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 08/2013
1	Thyroxine (Levothyroxine)FDA LinkGeneric 08/2013
1	purineIBA 10/2012
1	EnzymesIBA 10/2012
1	IntegrinsIBA 03/2009

Therapy/Procedure

14	Hematopoietic Stem Cell Transplantation 12/2023 - 03/2011
11	Cell Transplantation 01/2022 - 08/2011
9	Transplantation 01/2019 - 03/2011
6	Stem Cell Transplantation 12/2023 - 02/2014
1	Artificial Respiration (Mechanical Ventilation) 02/2023
1	Enzyme Replacement Therapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Therapeutics 01/2018